Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio-Techne (TECH) EPS (Weighted Average and Diluted) (2016 - 2025)

Bio-Techne has reported EPS (Weighted Average and Diluted) over the past 17 years, most recently at $0.24 for Q4 2025.

  • Quarterly results put EPS (Weighted Average and Diluted) at $0.24 for Q4 2025, up 9.09% from a year ago — trailing twelve months through Dec 2025 was $0.51 (down 49.0% YoY), and the annual figure for FY2025 was $0.46, down 56.19%.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $0.24 at Bio-Techne, roughly flat from $0.24 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for TECH hit a ceiling of $1.69 in Q3 2021 and a floor of -$2.24 in Q2 2021.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was $0.31 (2022), compared with a mean of $0.28.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): crashed 251.35% in 2021 and later skyrocketed 116.96% in 2022.
  • Bio-Techne's EPS (Weighted Average and Diluted) stood at $0.49 in 2021, then plummeted by 36.73% to $0.31 in 2022, then plummeted by 45.16% to $0.17 in 2023, then grew by 29.41% to $0.22 in 2024, then increased by 9.09% to $0.24 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were $0.24 (Q4 2025), $0.24 (Q3 2025), and -$0.11 (Q2 2025) per Business Quant data.